4.3 Article

Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Multidisciplinary Sciences

Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis

Zhengzheng Yan et al.

Summary: SLP76 plays an important role in RAGE-mediated pro-inflammatory signaling, and targeting its signaling pathway could be a therapeutic approach for sepsis.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells

Zijun Wang et al.

Summary: LCP2 expression is upregulated in metastatic skin cutaneous melanoma and associated with good overall survival. It is involved in multiple immune response pathways and positively correlated with molecules in TCR signaling and immune checkpoints in melanoma. High LCP2 expression is positively correlated with tumor-infiltrating CD8(+) T cells and acts as a prognostic biomarker for progression-free survival in patients receiving anti-PD1 immunotherapy.

SCIENTIFIC REPORTS (2021)

Correction Biochemistry & Molecular Biology

Biochemical AspectsofPD-L1 Regulation in Cancer Immunotherapy (vol 43, pg 1014, 2018)

Jinfang Zhang et al.

TRENDS IN BIOCHEMICAL SCIENCES (2019)

Review Biochemistry & Molecular Biology

Mechanisms Controlling PD-L1 Expression in Cancer

Jong-Ho Cha et al.

MOLECULAR CELL (2019)

Article Oncology

Mechanisms regulating PD-L1 expression on tumor and immune cells

Shuming Chen et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Oncology

Early Events in the Molecular Pathogenesis of Lung Cancer

Humam Kadara et al.

CANCER PREVENTION RESEARCH (2016)

Article Multidisciplinary Sciences

Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

Keisuke Kataoka et al.

NATURE (2016)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Multidisciplinary Sciences

Tissue-based map of the human proteome

Mathias Uhlen et al.

SCIENCE (2015)

Review Multidisciplinary Sciences

The future of immune checkpoint therapy

Padmanee Sharma et al.

SCIENCE (2015)

Article Immunology

Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo

Natalie A. Bezman et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Review Immunology

SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond

GA Koretzky et al.

NATURE REVIEWS IMMUNOLOGY (2006)

Article Immunology

Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection

JS Maltzman et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)